Stock screener

CNTA

Conviction 22HealthcareScan · Thu, Jun 25, 2026
CNTA$0.0000-100.00%
ResistanceSupportVol 14Insider sell
63 bars
8
Vol MA14 2.71M
Mar 25Apr 13Apr 30May 18Jun 5Jun 24
Centessa Pharmaceuticals plcBiotechnologywww.centessa.com ↗
Price0.0000
Change-100.00%
Gap-100.00%
Rel volume0.00×
Avg volume2.21M
Avg $ vol88.39M
SMA 2037.85
SMA 5038.90
SMA 20029.13
Price vs 50-100.00%
Price vs 200-100.00%
MA stackmixed
50/200 cross—
Supertrenddown · 12.74
RSI (14)3
MACD hist-2.57
MACD cross—
Stoch %K / %D0 / 65
ADX (14)46
+DI / −DI2 / 93
RSI divergence—
MACD divergenceBullish
ATR %—
ADR %0.48%
52w high40.50
52w low0.0000
From 52w high-100.00%
Above 52w low—
New 52w highNo
SqueezeFired
Bollinger width91.79%
%B-0.59
Donchian pos0.00%
Donchian high40.56
Donchian low0.0000
AVWAP (52w high)40.35
vs AVWAP high-100.00%
AVWAP (52w low)—
vs AVWAP low—
OBV trendUp
Chaikin MF (20)0.45
Today vs 20d0.00×
Avg vol (14d)2.71M
Avg vol (20d)2.21M
Avg $ vol (20d)88.39M
Market cap0
RS 3m (vs SPY)-112.26%
RS 6m (vs SPY)-107.74%
RS line new highNo
Trend template3/8
Technical rank—
1 week-100.00%
1 month-100.00%
3 months-100.00%
6 months-100.00%
1 year-100.00%
YTD-100.00%
P/E0.00
P/B0.00
P/S0.00
P/FCF0.00
EPS-1.46
Div yield—
ROE-40.53%
ROA-30.78%
Debt/Eq0.24
Current9.53
EV/EBITDA-0.26
Gross margin—
Net margin—
Rev growth—
EPS growth16.21%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value53.64M
Revenue0
Net income-79.24M
Gross profit—
Free cash flow-194.19M
IndustryBiotechnology
ExchangeNasdaq
Shares out154.66M
Employees129
ListedFri, May 28, 2021
Free float92.48M
Float %59.8%
Short interest2.57M
Days to cover2.6d
Short volume—
Squeeze score23 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction22 / 100
Pattern quality—
Tech rank—
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance39.89
Support39.47
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CNTA

All disclosures →
No recent disclosed trades by Congress in CNTA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CNTA · 10 sells

InsiderSideShares
Accardi Mario Alberto
Chief Executive Officer · Ordinary Shares · 2026-06-24
Disposition243.28K
Accardi Mario Alberto
Chief Executive Officer · Share Option (right to buy) · 2026-06-24
Disposition6.25K
Accardi Mario Alberto
Chief Executive Officer · Share Option (right to buy) · 2026-06-24
Disposition16.88K
Accardi Mario Alberto
Chief Executive Officer · Share Option (right to buy) · 2026-06-24
Disposition15.3K
Accardi Mario Alberto
Chief Executive Officer · Share Option (right to buy) · 2026-06-24
Disposition30K
Accardi Mario Alberto
Chief Executive Officer · Share Option (right to buy) · 2026-06-24
Disposition225K
Accardi Mario Alberto
Chief Executive Officer · Share Option (right to buy) · 2026-06-24
Disposition273K
Anderson Karen M.
Chief People Officer · Ordinary Shares · 2026-06-24
Disposition62.09K
Anderson Karen M.
Chief People Officer · Share Option (right to buy) · 2026-06-24
Disposition75K
Anderson Karen M.
Chief People Officer · Share Option (right to buy) · 2026-06-24
Disposition28.34K

SEC filings

EDGAR filings in CNTA · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.